Skip to main content
. 2010 Oct 9;55(12):3479–3487. doi: 10.1007/s10620-010-1442-8

Table 2.

Demographics and disease characteristics by race

Total population (n = 228)a White (n = 105) Black (n = 34) Hispanic (n = 35) Asian (n = 51) P-value
Percentage of study population 46.1 14.9 15.4 22.4
Proportion of each race in the overall healthcare system, 2007b 25 20 30 20
Proportion of each race in the overall San Francisco population, 2008c 45.6 6.8 14.1 31.3
Female, no. (%)d 94 (41.2) 42 (40.0) 12 (35.3) 16 (45.7) 23 (45.1) 0.76
Current smoker, no. (%)d 48 (21.1) 25 (23.8) 18 (52.9) 2 (5.7) 3 (4.8) <0.001
Mean age at diagnosis, years (SD)e 34.0 (14.1) 30.5 (11.8) 31.7 (14.3) 37.1 (16.0) 41.0 (14.6) <0.001
Disease duration, years (SD)e 7.9 (9.0) 8.6 (9.4) 12.1 (13.0) 5.2 (5.5) 5.4 (5.4) 0.003
Family history of IBD, no. (%)d 37 (16.2) 27 (25.7) 3 (8.8) 4 (11.4) 3 (5.9) 0.01
Diagnosis, no. (%)d, f 0.11
 Crohn’s disease 77 (33.4) 37 (35.2) 17 (50.0) 10 (28.6) 13 (25.5)
 Ulcerative colitis 150 (65.8) 68 (64.8) 16 (47.1) 25 (71.4) 38 (74.5)
 Inflammatory bowel disease, type unclassified 1 (0.4) 0 (0.0) 1 (2.9) 0 (0.0) 0 (0.0)

aIncludes three patients with “other” race

bData from [15]

cData from [18]

d P-value calculated using contingency tables and Pearson’s χ2 or Fisher’s exact test, as appropriate

e P-value calculated using analysis of variance (ANOVA)

fComparing patients with Crohn’s disease (CD) and ulcerative colitis (UC); excludes patients with inflammatory bowel disease type unclassified (IBDU)